1. Addition of Rifampicin to Bolton Broth to Inhibit Extended-Spectrum β-Lactamase-ProducingEscherichia colifor the Detection ofCampylobacter
- Author
-
Young-Jo Kim, Kidon Sung, Dongryeoul Bae, Young-Ji Kim, Saeed Ahmed Khan, Ji Young Jung, Kun-Ho Seo, and Jung-Whan Chon
- Subjects
0301 basic medicine ,Campylobacter ,030106 microbiology ,Biology ,medicine.disease_cause ,Trimethoprim ,Microbiology ,Agar plate ,03 medical and health sciences ,Cefoperazone ,Minimum inhibitory concentration ,medicine ,Vancomycin ,Escherichia coli ,Rifampicin ,Food Science ,medicine.drug - Abstract
Exponential growth of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in Campylobacter media has become a common problem for the detection of Campylobacter in chicken meats. We investigated the minimum inhibitory concentration of 40 ESBL-producing E. coli isolates from meats obtained from various countries against antibacterial agents in Bolton broth (cefoperazone, vancomycin, and trimethoprim). All ESBL-producing E. coli strains were resistant to cefoperazone and vancomycin, whereas 50% of them were resistant to trimethoprim and grew in Bolton broth. We found that 20 μg/mL of rifampicin inhibited the growth of trimethoprim-resistant E. coli strains. Hence, we added 20 μg/mL of rifampicin to Bolton broth to improve the isolation of Campylobacter from chicken carcass rinses. The isolation rate of Campylobacter was significantly higher in the modified broth (44 out of 58, 75.9%, P < 0.05) than in the normal broth (0 out of 58, 0%). Furthermore, the number of agar plates with non-Campylobacter spp. was much lower after enrichment in the modified broth (4 out of 58, 6.9%, P < 0.05) than in the normal broth (58 out of 58, 100%).
- Published
- 2017
- Full Text
- View/download PDF